Genascence’s $10.5 Million Series A Financing

Latham & Watkins advised Genascence in the transaction.Genascence Corporation (Genascence), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, has completed the…